GLP2-T is an investigational peptide of the glucagon-like peptide family, supplied for laboratory research and studied at the GLP-2 receptor.
A different receptor from GLP-1
Glucagon-like peptide-1 and glucagon-like peptide-2 are both produced by post-translational cleavage of proglucagon, but they act at distinct receptors with distinct biology. GLP-1 is the incretin associated with insulin secretion and appetite regulation. GLP-2 is not an incretin — its biology is intestinal.
The receptor’s unusual location
The GLP-2 receptor is a class B G-protein coupled receptor signalling through Gs coupling and cyclic AMP. What makes it mechanistically interesting is where it sits.
It is expressed on intestinal subepithelial myofibroblasts and enteroendocrine cells — not on the epithelial cells directly. So GLP-2 does not act on the absorptive surface itself; it acts on cells beneath it, which then release mediators affecting the epithelium. The effect on the epithelial layer is indirect.
That relay step is a real complication for research design: readouts at the epithelium reflect a two-stage process, not direct receptor engagement.
Research context
GLP-2 receptor biology is studied in relation to intestinal mucosal growth, crypt cell proliferation and barrier function. GLP2-T is a house designation for material supplied for this line of work; researchers should confirm identity and purity against the batch COA rather than relying on the product name.
Supplied lyophilised. See our reconstitution protocol for handling technique and diluent selection.
Every batch ships with a third-party certificate of analysis. View GLP2-T and its current COA.
Research use only
Isla Longevity supplies this compound for laboratory research use only. It is not approved by the FDA for human or veterinary use and is not for human consumption. This article summarises published research and is not medical guidance.
